Responsible for the design and development of venous access devices using our novel, patented biomaterial which is designed to prevent the most common and costly complications in venous access.
Access Vascular was founded in 2015 to address the most common and costly complications of intravenous therapy: infection, thrombosis and phlebitis. The company is developing a suite of venous access devices made from patented biomaterials which are highly biocompatible and have demonstrated 6X fewer complications. .